Member Info for ShareBag

Great timing and many will have a higher average. This company is a growth company and has shown this so far. Hold for a wee while I am confident we will see 3-4p + within a year. You just have to have a look at the previous rns’s and the revenue increase for the past year.

As someone mentioned these are no one off contracts but are part of framework agreements for 1 year plus. This means further revenues will be generated year on year. The hardest thing about trading or one of the hardest things, is keeping patient. Gl

Great news regarding covid-19 and waste water but going by some posts Integumen has many other services/products that they offer. Rinocloud is an additional revenue stream and Labskin has already been a key component to add revenue by doing business with several blue chipper clients. 2 mill so far, we can be easily above the guidance of 4 mill or at-least easily achieve it.

I am not sure if this has been mentioned but Omega already have a working HIV machine test which can be reconfigured for Covid-19. So for me this is fulfils me with confidence, together with the Governments backing. This mean a the test could be ready quicker than it would take others and a faster route to market. Big deal imo.

Even of you did not get in, in the 20’s, this will look cheap few days/weeks.

Some of those in from sub 10/20 p will sell and why not after a few bags. The thing shareholders need to see is that the sp has not moved much so sells have been soaked up nicely. The upside is STILL huge as any success in the drug could send the sp to pounds. Lets not get too excited but risk VS reward. I bought in yesterday but better late than never.

If we see 10 million (long way to achieve that) as someone mentioned, the sp should be around 8-10p imo. 10 mill rev and mcap at 2p is around 20mill - That would be undervalued. The fundamentals are Significantly better and other will se the value as soon as we can see that we have our guidance in H1 alone :)

I am still hanging on here. Volume is still pretty decent given the vol in oil stocks has dried up yesterday.

U sad tw£ t 2rein with you pathetic sly deramps which you are trying to cover up. Can easily tell from your last few posts. Not sure how you are trying to de-ramp this. Its not a aim company. Go back to drawing board because you seem to be clueless.

Anyone that can read a RNS, its all there but thanks for highlighting that. 2 million already in Q1 2020, thats what you need to know.

34 jobs being advertised at the moment! Seems they are pushing to meet demand.

Thats what some were waiting for. Excellent piece of news.

Not many drugs get to phase 3 and the money spent to get to phase 3 is massive. 5 mill upfront which is non-refundable is confidence. Also 12 mill in kitty with mcap being only 28mill

Only 39 million free float so not many

Don’t need to say but most if the ones showing as sells and buys. This stock is undervalued now. Placing raised £12 mill only last month and $5 mill upfront and further $45 mill in milestone payment. Must be confident of the drug passing FDA clearance. Will be moving up a-lot higher.

People seem to forget that the deal with MWG isn’t the only thing going for them despite the sp action. Labskin, deal with Parity, Rinocloud, Rawtest etc etc etc.

Going to say something obvious but needs to be said. We seem to forget that this along with the other framework agreements for several years more or less guarantees revenue not just for 2020 but for the years beyond. These massive Cosmetics and Pharma giants will be Testing not just their old products but new one’s as and when required. Lets not forget Research & Development using Labskin and Rinocloud’s platform.

The price is a gift of an opportunity to either average down or add Skin to the PF but as always do you own due-deligence.

Despite the sell off and the dreadful market which has lead to the collapse of the SP the core fundamentals still remain solid and setup to deliver revenues in years to come as we know from these framework agreements in the rns’s.

8 mill mcap and Integumen has 1 mill rev (unaudited) and 4 mill predicted for this year. If we achieve the 4 mill or more, I am confident the SP will surpass the recent highs. It will be a defining moment as this revenue will not be a one off with the framework agreements over several years.

Short term the sp has suffered and it has been painful for most but dyor. Will be waiting for the interims For 2020 H1 in Q3.

By the MM’s. Yes it was dropping before the CV stuff but its dropping more with such little volume. MM’s making most of the news

There you go - nothing has changed which has been said previously. There is definitely a massive side buying from down here. When the figures come I am sure the sp will reflect the value. For the time being, its a matter of either buying more or leaving it until we see growth in terms of the figures. Nothing has changed.

Been a very poor few weeks and here we are. The fact is fundamentals have not changed and no need to look to shareholders for fund. Bargain price down here before we hear about decent figures.

Some complete cun£s are out making most of it telling us it will go lower (it might) making the most out of the situation. Oh well.